Editorial: Risk of disease progression during active surveillance of papillary thyroid cancer.
暂无分享,去创建一个
[1] A. Miyauchi,et al. Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance , 2018, Surgery.
[2] Oscar Lin,et al. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance , 2017, JAMA otolaryngology-- head & neck surgery.
[3] R. Tuttle,et al. Surgical considerations for papillary thyroid microcarcinomas , 2017, Journal of surgical oncology.
[4] A. Miyauchi,et al. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma. , 2016, Thyroid : official journal of the American Thyroid Association.
[5] A. Miyauchi. Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid , 2016, World Journal of Surgery.
[6] I. Sugitani,et al. Management of low-risk papillary thyroid carcinoma: Unique conventional policy in Japan and our efforts to improve the level of evidence , 2010, Surgery Today.